ClinicalTrials.gov
public full text
Public Domain
Effect of Exenatide on Cortisol Secretion
The primary aim of the study is to describe the effect of single dose of 10 micrograms (μg) exenatide given subcutaneously (s/c) on cortisol secretion. Secondary outcomes involve ACTH and glucose levels.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus#414465
- Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality#1047850
- A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide#874935
- Headache Provocation of People Who Are Unable to Have Headache#1033503
- Glutamate Activity in Depression (GLADE)#1075138
Record · ID 979359
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive